Higher Peritoneal Protein Clearance as a Risk Factor for Cardiovascular Disease in Peritoneal Dialysis Patient

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Chang, Tae Ik ^a   Kang, Ea Wha ^a   Lee, Yong Kyu ^a   Shin, Sug Kyun ^a  

^a National Health Insurance Corporation   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; TRIACYLGLYCEROL; UREA;

ADULT; AGE; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETES MELLITUS; DIALYSATE LEVEL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; PERITONEAL DIALYSIS; PREDICTION; PREVALENCE; PROSPECTIVE STUDY; PROTEIN METABOLISM; PULSE PRESSURE; SOUTH KOREA; SURVIVAL RATE; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CREATININE; DIABETES MELLITUS; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PERITONEAL DIALYSIS; PERITONEUM; PROSPECTIVE STUDIES; PROTEINS; RISK FACTORS; SURVIVAL RATE; TIME FACTORS; UREA;

EID: 84873887654     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0056223     Document Type: Article

References (35)

1. Grassmann A, Gioberge S, Moeller S, Brown G, (2005) ESRD patients in 2004: global overview of patient numbers, treatment modalities and associated trends. Nephrol Dial Transplant 20: 2587-2593.
2. Krediet RT, Balafa O, (2010) Cardiovascular risk in the peritoneal dialysis patient. Nat Rev Nephrol 6: 451-460.
3. Zoccali C, (2006) Traditional and emerging cardiovascular and renal risk factors: an epidemiologic perspective. Kidney Int 70: 26-33.
4. Pecoits-Filho R, Lindholm B, Stenvinkel P, (2002) The malnutrition, inflammation, and atherosclerosis (MIA) syndrome - the heart of the matter. Nephrol Dial Transplant 17 (Suppl 11):: S28-S31.
5. Dukkipati R, Kopple JD, (2009) Causes and prevention of protein-energy wasting in chronic kidney failure. Semin Nephrol 29: 39-49.
6. Blumenkrantz MJ, Gahl GM, Kopple JD, Kamdar AV, Jones MR, et al. (1981) Protein losses during peritoneal dialysis. Kidney Int 19: 593-602.
7. Rippe B, (1993) A three-pore model of peritoneal transport. Perit Dial Int 13 (Suppl 2):: S35-S38.
8. Kaysen GA, (1998) Meta-analysis: Biological basis of hypoalbuminaemia in ESRD. J Am Soc Nephrol 9: 2368-2376.
9. Kathuria P, Moore HL, Khanna R, Twardowski ZJ, Goel S, et al. (1997) Effect of dialysis modality and membrane transport characteristics on dialysate protein losses of patients on peritoneal dialysis. Perit Dial Int 17: 449-454.
10. Margetts PJ, McMullin J, Rabbat CG, Churchill DN, (2000) Peritoneal membrane transport and hypoalbuminemia: Cause or effect? Perit Dial Int 20: 14-18.
11. Wang T, Heimburger O, Cheng HH, Bergstrom J, Lindholm B, (1999) Does a high peritoneal transport rate reflect a state of chronic inflammation? Perit Dial Int 19: 17-22.
12. Churchill DN, Thorpe KE, Nolph KD, Keshaviah PR, Oreopoulos DG, et al. (1998) Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients. The Canada-USA (CANUSA) Peritoneal Dialysis Study Group. J Am Soc Nephrol 9: 1285-1292.
13. Rumpsfeld M, McDonald SP, Johnson DW, (2006) Higher peritoneal transport status is associated with higher mortality and technique failure in the Australian and New Zealand peritoneal dialysis patient populations. J Am Soc Nephrol 17: 271-278.
14. Brimble KS, Walker M, Margetts PJ, Kundhal KK, Rabbat CG, (2006) Meta-analysis: Peritoneal membrane transport, mortality, and technique failure in peritoneal dialysis. J Am Soc Nephrol 17: 2591-2598.
15. Wiggins KJ, McDonald SP, Brown FG, Rosman JB, Johnson DW, (2007) High membrane transport status on peritoneal dialysis is not associated with reduced survival following transfer to haemodialysis. Nephrol Dial Transplant 22: 3005-3012.
16. Johnson DW, Hawley CM, McDonald SP, Brown FG, Rosman JB, et al. (2010) Superior survival of high transporters treated with automated versus continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 25: 1973-1979.
17. Rodrigues AS, Almeida M, Fonseca I, Martins M, Carvalho MJ, et al. (2006) Peritoneal fast transport in incident peritoneal dialysis patients is not consistently associated with systemic inflammation. Nephrol Dial Transplant 21: 763-769.
18. Szeto CC, Chow KM, Lam CW, Cheung R, Kwan BC, et al. (2005) Peritoneal albumin excretion is a strong predictor of cardiovascular events in peritoneal dialysis patients: A prospective cohort study. Perit Dial Int 25: 445-452.
19. Nakamoto H, Imai H, Kawanishi H, Nakamoto M, Minakuchi J, et al. (2002) Effect of diabetes on peritoneal function assessed by personal dialysis capacity test in patients undergoing CAPD. Am J Kidney Dis 40: 1045-1054.
20. Heaf JG, Sarac S, Afzal S, (2005) A high peritoneal large pore fluid flux causes hypoalbuminaemia and is a risk factor for death in peritoneal dialysis patients. Nephrol Dial Transplant 20: 2194-2201.
21. Van Biesen W, Van der Tol A, Veys N, Dequidt C, Vijt D, et al. (2006) The personal dialysis capacity test is superior to the peritoneal equilibration test to discriminate inflammation as the cause of fast transport status in peritoneal dialysis patients. Clin J Am Soc Nephrol 1: 269-274.
22. Perl J, Huckvale K, Chellar M, John B, Davies SJ, (2009) Peritoneal protein clearance and not peritoneal membrane transport status predicts survival in a contemporary cohort of peritoneal dialysis patients. Clin J Am Soc Nephrol 4: 1201-1206.
23. Elsurer R, Afsar B, Sezer S, Ozdemir FN, Haberal M, (2009) Peritoneal albumin leakage: 2 year prospective cardiovascular event occurrence and patient survival analysis. Nephrology (Carlton) 14: 712-715.
24. Sanchez-Villanueva R, Bajo A, Del Peso G, Fernandez-Reyes MJ, Gonzalez E, et al. (2009) Higher daily peritoneal protein clearance when initiating peritoneal dialysis is independently associated with peripheral arterial disease (PAD): A possible new marker of systemic endothelial dysfunction? Nephrol Dial Transplant 24: 1009-1014.
25. Balafa O, Halbesma N, Struijk DG, Dekker FW, Krediet RT, (2011) Peritoneal albumin and protein losses do not predict outcome in peritoneal dialysis patients. Clin J Am Soc Nephrol 6: 561-566.
26. Nolph KD, Moore HL, Prowant B, Meyer M, Twardowski ZJ, et al. (1993) Cross sectional assessment of weekly urea and creatinine clearances and indices of nutrition in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 13: 178-183.
27. Weir MR, (2007) Microalbuminuria and cardiovascular disease. Clin J Am Soc Nephrol 2: 581-590.
28. De Mutsert R, Grootendorst DC, Indemans F, Boeschoten EW, Krediet R, et al. (2009) Association between serum albumin and mortality in dialysis patients is partly explained by inflammation, and not by malnutrition. J Ren Nutr 19: 127-135.
29. Friedman AN, Fadem SZ, (2010) Reassessment of albumin as a nutritional marker in kidney disease. J Am Soc Nephrol 21: 223-230.
30. Malone AF, Reddan DN, (2010) Pulse pressure. Why is it important? Perit Dial Int 30: 265-268.
31. Lee H, Hwang YH, Jung JY, Na KY, Kim HS, et al. (2009) Comparison of vascular calcification scoring systems using plain radiographs to predict vascular stiffness in peritoneal dialysis patients. Nephrology (Carlton) 16: 656-662.
32. Oh KH, Jung JY, Yoon MO, Song A, Lee H, et al. (2010) Intra-peritoneal interleukin-6 system is a potent determinant of the baseline peritoneal solute transport in incident peritoneal dialysis patients. Nephrol Dial Transplant 25: 1639-1646.
33. Kopple JD, (1994) Effect of nutrition on morbidity and mortality in maintenance dialysis patients. Am J Kidney Dis 24: 1002-1009.
34. Canada-USA (CANUSA) Peritoneal Dialysis Study Group (1996) Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes. J Am Soc Nephrol 7: 198-207.
35. Han SH, Han DS, (2012) Nutrition in patients on peritoneal dialysis. Nat Rev Nephrol 8: 163-175.